MG217 Psoriasis Medicated multi-symptom
US over-the-counter (OTC) label
In the United States, these products are sold as over-the-counter (OTC) drugs: sunscreens, antiperspirants, anti-dandruff products, anticavity toothpastes, acne products and skin protectants. The label separates active and inactive ingredients. In the European Union, a product with a cosmetic purpose must comply with Regulation (EC) No 1223/2009. A filter or active allowed in the United States may not be authorised for that use in the EU. The classification depends on the purpose: a hand sanitiser may fall under biocides and an acne treatment under medicines. This analysis applies the cosmetic rules to the ingredients without establishing the compliance of the finished product. The formula sold in Europe under the same name may be different.
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Stated use in the United States
Purpose Psoriasis, Seborrheic Dermatitis, Dandruff Treatment
Published active ingredients
Coal Tar 2% (from Coal Tar Topical Solution, USP 20%)
Published inactive ingredients
Petrolatum, C12-15 Alkyl Benzoate, Bis-Diglyceryl Polyacyladipate-2, PEG/PPG-18/18 Dimethicone, Glyceryl Stearate, PEG-100 Stearate, Vitamin E Acetate, Vitamin A (retinyl palmitate), Vitamin D 3 (cholecalciferol)
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Cosmetic analysis in the European Union
2 ingredients prohibited in cosmetics in the European Union: Coal Tar 2%, Vitamin D 3 (cholecalciferol). A product that contains it should no longer be sold in the Union. 1 ingredient prohibited, except for the cases the Regulation provides: Petrolatum; its rule says which. 1 ingredient allowed under conditions (maximum concentration, product types): some active ingredient concentrations are printed; the other conditions and the product's classification in the European Union remain to be checked. 10 names recognised out of 12.
Warning: 2 names out of 12 are not recognised ((from Coal Tar Topical Solution, USP 20%), Acetate): nothing below covers them.
- Pregnancy and breastfeeding : Prohibition or serious classification CHOLECALCIFEROL
Coal Tar 2%, (from Coal Tar Topical Solution, USP 20%), Petrolatum, C12-15 Alkyl Benzoate, Bis-Diglyceryl Polyacyladipate-2, PEG/PPG-18/18 Dimethicone, Glyceryl Stearate, PEG-100 Stearate, Vitamin E, Acetate, Vitamin A (retinyl palmitate), Vitamin D 3 (cholecalciferol)
Who it concerns
For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.
Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.
Pregnancy and breastfeeding
- Prohibition or serious classification CHOLECALCIFEROLAn EU act identifies it as an endocrine disruptor for human health: Regulation (EU) 2019/637 (approval, biocidal products).
Read on the label
- Worth watching RETINYL PALMITATEAnnex III, entry 376, requires this to be printed on the pack: “For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’.”. Regulation (EU) 2024/996 gives the reason: to inform people already exposed to vitamin A from food and food supplements that a cosmetic may add to an excess (recital 3).
No official text covers the recognised ingredients for: babies and children, skin, eyes and allergies, environment.
For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.
Selling elsewhere
Ingredients of this list that are prohibited, prohibited in some cases or subject to conditions in the other countries whose rules we record (nothing changes for sale in France). Absence is not approval: several countries only allow the preservatives, UV filters and colorants on their lists, and the function of an ingredient in the product is not known. What is covered for each country.
| Country | Prohibited | Prohibited in some cases | Subject to conditions |
|---|---|---|---|
| United Kingdom | Coal Tar 2%, Petrolatum, Vitamin D 3 (cholecalciferol) | - | - |
| Canada | Coal Tar 2% | - | Vitamin A (retinyl palmitate), Vitamin D 3 (cholecalciferol) |
| South Korea | Coal Tar 2%, Vitamin D 3 (cholecalciferol) | - | Vitamin E |
| China | Coal Tar 2%, Petrolatum, Vitamin D 3 (cholecalciferol) | - | - |
| Australia | - | Coal Tar 2% | - |
| ASEAN | Coal Tar 2%, Vitamin D 3 (cholecalciferol) | Petrolatum | - |
| Taiwan | Coal Tar 2%, Vitamin D 3 (cholecalciferol) | - | - |
| Brazil | Coal Tar 2%, Petrolatum, Vitamin D 3 (cholecalciferol) | - | - |
No prohibition or condition found in the recorded lists for: United States (federal), Washington State, California, Japan.
Ingredient by ingredient
The line under each name gives its rule in the European Union (legend below). Click a name for its page.
Hover over or tap a badge for its meaning.
Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.
| On the label | Glossary name | Rule in the European Union | Classified hazard (cancer, DNA, reproduction) |
|---|---|---|---|
| Coal Tar 2% | COAL TAR | Prohibited in cosmetics (Annex II) | Carcinogenic: known effect (category 1A, CLP classification) |
| (from Coal Tar Topical Solution, USP 20%) | not recognised | Name not recognised in the European glossary | unknown |
| Petrolatum | PETROLATUM | Prohibited unless refining is demonstrated (Annex II) | none |
| C12-15 Alkyl Benzoate | C12-15 ALKYL BENZOATE | No specific rule in the Cosmetics Regulation | none |
| Bis-Diglyceryl Polyacyladipate-2 | BIS-DIGLYCERYL POLYACYLADIPATE-2 | No specific rule in the Cosmetics Regulation | none |
| PEG/PPG-18/18 Dimethicone | PEG/PPG-18/18 DIMETHICONE | No specific rule in the Cosmetics Regulation | none |
| Glyceryl Stearate | GLYCERYL STEARATE | No specific rule in the Cosmetics Regulation | none |
| PEG-100 Stearate | PEG-100 STEARATE | No specific rule in the Cosmetics Regulation | none |
| Vitamin E | TOCOPHEROL Certainty medium: name found in a list printed without commas | No specific rule in the Cosmetics Regulation | none |
| Acetate | not recognised | Name not recognised in the European glossary | unknown |
| Vitamin A (retinyl palmitate) | RETINYL PALMITATE Certainty high: the exact glossary name is printed in brackets | Allowed with restrictions (Annex III) Annex III, entry 376: products: (a) Body lotion (b) other leave-on and rinse-off products; maximum concentration: (a) 0.05% Retinol EquivalentContent expressed as retinol: for an ester (retinyl acetate or palmitate), the amount of retinol it provides. (RE) (b) 0.3% RE | none |
| Vitamin D 3 (cholecalciferol) | CHOLECALCIFEROL Certainty high: the exact glossary name is printed in brackets | Prohibited in cosmetics (Annex II) | Identified as an endocrine disruptor at EU level |
Product record
- Brand or trade name
- MG217 Psoriasis Medicated multi-symptom
- Manufacturer
- Wisconsin Pharmacal Company
- Label date
- 20 March 2026
Label in the official openFDA API. This is the label date; the formula may have changed. Compare with the packaging.
List in the official revision dated (register: openFDA: US OTC product labels, analysed under European cosmetic rules).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “MG217 Psoriasis Medicated multi-symptom”, https://compoatlas.com/en/cosmetics/united-states/7cb04d20-9b3c-27bb-e053-2a91aa0a5bc4-mg217-psoriasis-medicated-multi-symptom, updated 20 March 2026.